What Does the Historical and Current Hospital And Nursing Home Probiotics Market Size Trend Indicate?
The hospital and nursing home probiotics market has seen considerable growth due to a variety of factors.
• The expansion of the probiotics market in hospitals and nursing homes has been significant in recent years. The market value is projected to rise from $1.51 billion in 2024 to $1.69 billion in 2025, with a compound annual growth rate (CAGR) of 11.81%.
This growth during the historical period is the result of various factors such as a growing understanding of gut health, an increased incidence of gastrointestinal issues, a rise in the use of probiotics in healthcare environments, and an accumulation of proof verifying the health advantages of probiotics.
How Will the Hospital And Nursing Home Probiotics Market Size Evolve over the Forecast Period?
The hospital and nursing home probiotics market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the market size for probiotics in hospitals and nursing homes is predicted to experience a substantial increase. It is forecasted to attain a value of $2.61 billion in 2029, flourishing at a compound annual growth rate (CAGR) of 11.44%.
The surge during this predicted timeframe is related to factors such as the proliferating acceptance of probiotics, an escalating requirement for solutions pertaining to digestive health, amplified consciousness about probiotics, a heightened emphasis on curtailing hospital-borne infections (HAIs), and an increase in investments in probiotic-driven medical nutrition. Foreseen trends within this period comprise advancements in probiotic compositions, enhancements in delivering methodologies for particular healthcare environments, probiotic innovations aimed at infection prevention, the creation of unique probiotics for aged and immunosuppressed patients, and the fusion of digital solutions.
What Are the Critical Driver Fuelling the Hospital And Nursing Home Probiotics Market's Growth?
The escalating occurrence of disorders related to the digestive system is anticipated to spur the expansion of the probiotics market within hospitals and nursing homes. The spectrum of gastrointestinal disorders encompasses conditions like irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), and chronic constipation. Elevated occurrences of such disorders can largely be traced back to factors like bad eating habits, an uptick in processed food consumption, inactive lifestyles, and heightened stress levels. Probiotics employed in hospitals and nursing homes help overcome such digestive issues by reinstating the equilibrium of favorable intestinal bacteria, fostering digestive health, and easing symptoms ranging from diarrhea and chronic constipation, to bloating. The IBD Registry, a non-profit body hailing from the UK, reported in December 2023 that the number of individuals diagnosed with Inflammatory Bowel Disease (IBD) had risen to over 5,300, illustrating an increase of more than 3,000 individuals from 2022. In effect, the upward trend in gastrointestinal disorders prevalence is propelling the probiotics market's growth across hospitals and nursing homes.
What Key Areas Define The Segmentation Of The Global Hospital And Nursing Home Probiotics Market?
The hospital and nursing home probiotics market covered in this report is segmented –
1) By Indication: Antibiotic-Associated Diarrhea, Irritable Bowel Syndrome, Clostridium difficile Infection, Inflammatory Bowel Disease, General Gut Health
2) By Formulation Type: Capsules, Powder, Liquid, Soft Chew, Probiotic Yogurt
3) By Patient Group: Infants, Adults, Elderly, Immunocompromised Patients, Patients With Gastrointestinal Disorders
4) By Distribution Channel: Hospitals, Nursing Homes, Pharmacies, Online Retail, Healthcare Facilities
5) By Application: Gut Health, Immunity, Wellness, Other Applications
Subsegments:
1) By Antibiotic-Associated Diarrhea (AAD): Prevention of AAD, Treatment of AAD
2) By Irritable Bowel Syndrome (IBS):IBS With Diarrhea (IBS-D), IBS With Constipation (IBS-C), Mixed IBS (IBS-M)
3) By Clostridium Difficile Infection (CDI): Prevention of CDI Recurrence, Treatment Of CDI
4) By Inflammatory Bowel Disease (IBD):Crohn’s Disease, Ulcerative Colitis
5) By General Gut Health: Immune System Support, Digestive Health, Gut Microbiome Restoration
Pre-Book The Hospital And Nursing Home Probiotics Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Hospital And Nursing Home Probiotics Market?
Leading businesses in the hospital and nursing home probiotics market are prioritizing the development of inventive products like probiotic solutions to boost gut health in patients, expedite recovery periods, and mitigate the side effects associated with antibiotics. Probiotic solutions are products comprising live microorganisms that, when consumed in sufficient quantities, provide health benefits, chiefly by enhancing the balance of good bacteria in the digestive system. For example, in October 2024, Probi AB, a biotechnology firm from Sweden which specializes in probiotics, unveiled Metabolic Health by Probi, crafted specifically for healthcare environments. Metabolic Health by Probi is a scientifically supported probiotic solution that promotes metabolic health, cardiovascular wellness, weight regulation, and blood pressure control by integrating two proprietary probiotic strains, Lactiplantibacillus plantarum 299v (LP299V) and Lacticaseibacillus paracasei 8700:2 (L. Paracasei 8700:2).
Who Are the Key Players in the Hospital And Nursing Home Probiotics Market?
Major companies operating in the hospital and nursing home probiotics market are include:
• Nestlé Health Science
• BASF SE
• Procter & Gamble Company
• Abbott Laboratories
• Lactalis Group
• Danone S.A.
• General Mills Inc.
• Arla Foods Group
• DuPont de Nemours Inc.
• Kerry Group plc
• Koninklijke DSM N.V.
• Glanbia PLC
• Yakult Honsha Co. Ltd.
• Chr. Hansen Holding A/S
• Lallemand Inc.
• BioGaia AB
• Klaire Labs
• SymbioPharm GmbH
• Synlogic Inc.
• Vitakem Nutraceuticals
What Is The Most Dominant Region In The Hospital And Nursing Home Probiotics Market?
North America was the largest region in the hospital and nursing home probiotics market in 2024. The regions covered in the hospital and nursing home probiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
